Pien-Tze-Huang alleviates CCl4-induced liver fibrosis through the inhibition of HSC autophagy and the TGF-β1/Smad2 pathway
Ethnopharmacological relevance: Pien-Tze-Huang (PZH)—a traditional Chinese medicine (TCM) compound—has been employed to treat various liver inflammation and tumors for over 10 decades. Interestingly, most of the pharmacological effects had been validated and explored toward liver ailment along with...
Main Authors: | Yuqin Zhang, Liping Hua, Chunfeng Lin, Mingzhou Yuan, Wei Xu, Anand Raj D., Baskar Venkidasamy, Carlos L. Cespedes-Acuna, Shivraj Hariram Nile, Guohong Yan, Haiyin Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.937484/full |
Similar Items
-
Therapeutic Potential of Pien-Tze-Huang: A Review on Its Chemical Composition, Pharmacology, and Clinical Application
by: Lili Huang, et al.
Published: (2019-09-01) -
Evaluation and mechanism study of Pien Tze Huang against EV-A71 infection
by: Huiqiang Wang, et al.
Published: (2023-10-01) -
Pien Tze Huang alleviate the joint inflammation in collagen-induced arthritis mice
by: YongQi Deng, et al.
Published: (2020-03-01) -
The anti-inflammatory effect of Pien Tze Huang in non-alcoholic fatty liver disease
by: Baohuan Lian, et al.
Published: (2022-07-01) -
Pien-tze-huang promotes wound healing in streptozotocin-induced diabetes models associated with improving oxidative stress via the Nrf2/ARE pathway
by: Ying Liu, et al.
Published: (2023-01-01)